Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 5959721, 11 pages
http://dx.doi.org/10.1155/2016/5959721
Review Article

Roles of pRB in the Regulation of Nucleosome and Chromatin Structures

Advanced Research Facilities & Services, Preeminent Medical Photonics Education & Research Center, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka 431-3192, Japan

Received 8 September 2016; Accepted 8 November 2016

Academic Editor: Keiko Kawauchi

Copyright © 2016 Chiharu Uchida. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. G. Knudson Jr., “Mutation and cancer: statistical study of retinoblastoma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 68, no. 4, pp. 820–823, 1971. View at Publisher · View at Google Scholar · View at Scopus
  2. W. K. Cavenee, T. P. Dryja, R. A. Phillips et al., “Expression of recessive alleles by chromosomal mechanisms in retinoblastoma,” Nature, vol. 305, no. 5937, pp. 779–784, 1983. View at Publisher · View at Google Scholar · View at Scopus
  3. W. K. Cavenee, M. F. Hansen, M. Nordenskjold et al., “Genetic origin of mutations predisposing to retinoblastoma,” Science, vol. 228, no. 4698, pp. 501–503, 1985. View at Publisher · View at Google Scholar · View at Scopus
  4. S. H. Friend, R. Bernards, S. Rogelj et al., “A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma,” Nature, vol. 323, no. 6089, pp. 643–646, 1986. View at Publisher · View at Google Scholar · View at Scopus
  5. R. A. Weinberg, “The retinoblastoma protein and cell cycle control,” Cell, vol. 81, no. 3, pp. 323–330, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. R. J. White, “Regulation of RNA polymerases i and III by the retinoblastoma protein: a mechanism for growth control?” Trends in Biochemical Sciences, vol. 22, no. 3, pp. 77–80, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Dyson, “The regulation of E2F by pRB-family proteins,” Genes & Development, vol. 12, no. 15, pp. 2245–2262, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Takahashi, J. B. Rayman, and B. D. Dynlacht, “Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression,” Genes & Development, vol. 14, no. 7, pp. 804–816, 2000. View at Google Scholar · View at Scopus
  9. R. Ferreira, I. Naguibneva, L. L. Pritchard, S. Ait-Si-Ali, and A. Harel-Bellan, “The Rb/chromatin connection and epigenetic control: opinion,” Oncogene, vol. 20, no. 24, pp. 3128–3133, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Brehm, E. A. Miska, D. J. McCance, J. L. Reid, A. J. Bannister, and T. Kouzarides, “Retinoblastoma protein recruits histone deacetylase to repress transcription,” Nature, vol. 391, no. 6667, pp. 597–601, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. K. D. Robertson, S. Ait-Si-Ali, T. Yokochi, P. A. Wade, P. L. Jones, and A. P. Wolffe, “DNMT1 forms a complex with RB, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters,” Nature Genetics, vol. 25, no. 3, pp. 338–342, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. V. Pennaneach, I. Salles-Passador, A. Munshi et al., “The large subunit of replication factor C promotes cell survival after DNA damage in an L×C×E motif- and Rb-dependent manner,” Molecular Cell, vol. 7, no. 4, pp. 715–727, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. J. L. Dunaief, B. E. Strober, S. Guha et al., “The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest,” Cell, vol. 79, no. 1, pp. 119–130, 1994. View at Publisher · View at Google Scholar · View at Scopus
  14. B. E. Strober, J. L. Dunaief, Guha, and S. P. Goff, “Functional interactions between the hBRM/hBRG1 transcriptional activators and the pRB family of proteins,” Molecular and Cellular Biology, vol. 16, no. 4, pp. 1576–1583, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. S. J. Nielsen, R. Schneider, U.-M. Bauer et al., “Rb targets histone H3 methylation and HP1 to promoters,” Nature, vol. 412, no. 6846, pp. 561–565, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Dahiya, M. R. Gavin, R. X. Luo, and D. C. Dean, “Role of the LXCXE binding site in Rb function,” Molecular and Cellular Biology, vol. 20, no. 18, pp. 6799–6805, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Giacinti and A. Giordano, “RB and cell cycle progression,” Oncogene, vol. 25, no. 38, pp. 5220–5227, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. C. M. Chau, Z. Deng, H. Kang, and P. M. Lieberman, “Cell cycle association of the retinoblastoma protein Rb and the histone demethylase LSD1 with the Epstein-Barr virus latency promoter Cp,” Journal of Virology, vol. 82, no. 7, pp. 3428–3437, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. A. R. Fattaey, K. Helin, M. S. Dembski et al., “Characterization of the retinoblastoma binding proteins RBP1 and RBP2,” Oncogene, vol. 8, no. 11, pp. 3149–3156, 1993. View at Google Scholar · View at Scopus
  20. J. Christensen, K. Agger, P. A. C. Cloos et al., “RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3,” Cell, vol. 128, no. 6, pp. 1063–1076, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Chicas, X. Wang, C. Zhang et al., “Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence,” Cancer Cell, vol. 17, no. 4, pp. 376–387, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Khidr and P.-L. Chen, “RB, the conductor that orchestrates life, death and differentiation,” Oncogene, vol. 25, no. 38, pp. 5210–5219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. N. E. Simon and A. Schwacha, “The Mcm2-7 replicative helicase: a promising chemotherapeutic target,” BioMed Research International, vol. 2014, Article ID 549719, 14 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. M. S. Longworth, A. Herr, J.-Y. Ji, and N. J. Dyson, “RBF1 promotes chromatin condensation through a conserved interaction with the Condensin II protein dCAP-D3,” Genes & Development, vol. 22, no. 8, pp. 1011–1024, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. A. L. Manning, M. S. Longworth, and N. J. Dyson, “Loss of pRB causes centromere dysfunction and chromosomal instability,” Genes & Development, vol. 24, no. 13, pp. 1364–1376, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. C. H. Coschi, A. L. Martens, K. Ritchie et al., “Mitotic chromosome condensation mediated by the retinoblastoma protein is tumor-suppressive,” Genes & Development, vol. 24, no. 13, pp. 1351–1363, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. C. H. Coschi, C. A. Ishak, D. Gallo et al., “Haploinsufficiency of an RB-E2F1-condensin II complex leads to aberrant replication and aneuploidy,” Cancer Discovery, vol. 4, no. 7, pp. 840–853, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Uchida, T. Hattori, H. Takahashi, N. Yamamoto, M. Kitagawa, and Y. Taya, “Interaction between RB protein and NuMA is required for proper alignment of spindle microtubules,” Genes to Cells, vol. 19, no. 2, pp. 89–96, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. F. P. Fiorentino, I. Marchesi, and A. Giordano, “On the role of retinoblastoma family proteins in the establishment and maintenance of the epigenetic landscape,” Journal of Cellular Physiology, vol. 228, no. 2, pp. 276–284, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Meier and A. Brehm, “Chromatin regulation: how complex does it get?” Epigenetics, vol. 9, no. 11, pp. 1485–1495, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Uchida, “The retinoblastoma protein: functions beyond the G1-S regulator,” Current Drug Targets, vol. 13, no. 13, pp. 1622–1632, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. P. M. Brownlee, C. Meisenberg, and J. A. Downs, “The SWI/SNF chromatin remodelling complex: its role in maintaining genome stability and preventing tumourigenesis,” DNA Repair, vol. 32, pp. 127–133, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. O. A. Romero, M. Torres-Diz, E. Pros et al., “MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1,” Cancer discovery, vol. 4, no. 3, pp. 292–303, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Singh, M. Krajewski, A. Mikolajka, and T. A. Holak, “Molecular determinants for the complex formation between the retinoblastoma protein and LXCXE sequences,” The Journal of Biological Chemistry, vol. 280, no. 45, pp. 37868–37876, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. M. W. Strobeck, D. N. Reisman, R. W. Gunawardena et al., “Compensation of BRG-1 function by Brm. Insight into the role of the core SWI·SNF subunits in retinoblastoma tumor suppressor signaling,” The Journal of Biological Chemistry, vol. 277, no. 7, pp. 4782–4789, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Coisy-Quivy, O. Disson, V. Roure, C. Muchardt, J.-M. Blanchard, and J.-C. Dantonel, “Role for Brm in cell growth control,” Cancer Research, vol. 66, no. 10, pp. 5069–5076, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Trouche, C. Le Chalony, C. Muchardt, M. Yaniv, and T. Kouzarides, “RB and hbrm cooperate to repress the activation functions of E2F1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 21, pp. 11268–11273, 1997. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Lai, B. K. Kennedy, D. A. Barbie et al., “RBP1 recruits the mSIN3-histone deacetylase complex to the pocket of retinoblastoma tumor suppressor family proteins found in limited discrete regions of the nucleus at growth arrest,” Molecular and Cellular Biology, vol. 21, no. 8, pp. 2918–2932, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. A. R. Meloni, E. J. Smith, and J. R. Nevins, “A mechanism for Rb/p130-mediated transcription repression involving recruitment of the CtBP corepressor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 17, pp. 9574–9579, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. A. J. Morrison, C. Sardet, and R. E. Herrera, “Retinoblastoma protein transcriptional repression through histone deacetylation of a single nucleosome,” Molecular and Cellular Biology, vol. 22, no. 3, pp. 856–865, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Ropero and M. Esteller, “The role of histone deacetylases (HDACs) in human cancer,” Molecular Oncology, vol. 1, no. 1, pp. 19–25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. H. P. Chen, Y. T. Zhao, and T. C. Zhao, “Histone deacetylases and mechanisms of regulation of gene expression,” Critical Reviews in Oncogenesis, vol. 20, no. 1-2, pp. 35–47, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Manal, M. J. N. Chandrasekar, J. Gomathi Priya, and M. J. Nanjan, “Inhibitors of histone deacetylase as antitumor agents: a critical review,” Bioorganic Chemistry, vol. 67, pp. 18–42, 2016. View at Publisher · View at Google Scholar
  44. A. Newbold, K. J. Falkenberg, M. H. Prince, and R. W. Johnstone, “How do tumor cells respond to HDAC inhibition?” FEBS Journal, vol. 283, no. 22, pp. 4032–4046, 2016. View at Publisher · View at Google Scholar
  45. S. Rea, F. Eisenhaber, D. O'Carroll et al., “Regulation of chromatin structure by site-specific histone H3 methyltransferases,” Nature, vol. 406, no. 6796, pp. 593–599, 2000. View at Publisher · View at Google Scholar · View at Scopus
  46. M. M. Müller, B. Fierz, L. Bittova, G. Liszczak, and T. W. Muir, “A two-state activation mechanism controls the histone methyltransferase Suv39h1,” Nature Chemical Biology, vol. 12, no. 3, pp. 188–193, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Zhang, S. Cooper, and N. Brockdorff, “The interplay of histone modifications —writers that read,” EMBO Reports, vol. 16, no. 11, pp. 1467–1481, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. A. J. Bannister, P. Zegerman, J. F. Partridge et al., “Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain,” Nature, vol. 410, no. 6824, pp. 120–124, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. D. Canzio, A. Larson, and G. J. Narlikar, “Mechanisms of functional promiscuity by HP1 proteins,” Trends in Cell Biology, vol. 24, no. 6, pp. 377–386, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. S. H. Kwon and J. L. Workman, “The heterochromatin protein 1 (HP1) family: put away a bias toward HP1,” Molecules and Cells, vol. 26, no. 3, pp. 217–227, 2008. View at Google Scholar · View at Scopus
  51. E. Minc, Y. Allory, H. J. Worman, J.-C. Courvalin, and B. Buendia, “Localization and phosphorylation of HP1 proteins during the cell cycle in mammalian cells,” Chromosoma, vol. 108, no. 4, pp. 220–234, 1999. View at Publisher · View at Google Scholar · View at Scopus
  52. A. L. Nielsen, M. Oulad-Abdelghani, J. A. Ortiz, E. Remboutsika, P. Chambon, and R. Losson, “Heterochromatin formation in mammalian cells: interaction between histones and HP1 Proteins,” Molecular Cell, vol. 7, no. 4, pp. 729–739, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Aagaard, G. Laible, P. Selenko et al., “Functional mammalian homologues of the Drosophila PEV-modifier Su(var)3-9 encode centromere-associated proteins which complex with the heterochromatin component M31,” The EMBO Journal, vol. 18, no. 7, pp. 1923–1938, 1999. View at Publisher · View at Google Scholar · View at Scopus
  54. G. Schotta, A. Ebert, V. Krauss et al., “Central role of Drosophila SU(VAR)3-9 in histone H3-K9 methylation and heterochromatic gene silencing,” The EMBO Journal, vol. 21, no. 5, pp. 1121–1131, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. A. P. Young and G. D. Longmore, “Differences in stability of repressor complexes at promoters underlie distinct roles for Rb family members,” Oncogene, vol. 23, no. 3, pp. 814–823, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Narita, S. Nũnez, E. Heard et al., “Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence,” Cell, vol. 113, no. 6, pp. 703–716, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. P. Sdek, P. Zhao, Y. Wang et al., “Rb and p130 control cell cycle gene silencing to maintain the postmitotic phenotype in cardiac myocytes,” Journal of Cell Biology, vol. 194, no. 3, pp. 407–423, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. G. Nishibuchi and J.-I. Nakayama, “Biochemical and structural properties of heterochromatin protein 1: understanding its role in chromatin assembly,” Journal of Biochemistry, vol. 156, no. 1, pp. 11–20, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. O. Vaute, E. Nicolas, L. Vandel, and D. Trouche, “Functional and physical interaction between the histone methyl transferase Suv39H1 and histone deacetylases,” Nucleic Acids Research, vol. 30, no. 2, pp. 475–481, 2002. View at Publisher · View at Google Scholar · View at Scopus
  60. L. Vandel, E. Nicolas, O. Vaute, R. Ferreira, S. Ait-Si-Ali, and D. Trouch, “Transcriptional repression by the retinoblastoma protein through the recruitment of a histone methyltransferase,” Molecular and Cellular Biology, vol. 21, no. 19, pp. 6484–6494, 2001. View at Publisher · View at Google Scholar · View at Scopus
  61. Y.-J. Shi, C. Matson, F. Lan, S. Iwase, T. Baba, and Y. Shi, “Regulation of LSD1 histone demethylase activity by its associated factors,” Molecular Cell, vol. 19, no. 6, pp. 857–864, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. E. V. Benevolenskaya, H. L. Murray, P. Branton, R. A. Young, and W. G. Kaelin Jr., “Binding of pRB to the PHD protein RBP2 promotes cellular differentiation,” Molecular Cell, vol. 18, no. 6, pp. 623–635, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Maiques-Diaz and T. C. Somervaille, “LSD1: biologic roles and therapeutic targeting,” Epigenomics, vol. 8, no. 8, pp. 1103–1116, 2016. View at Publisher · View at Google Scholar
  64. N. Lopez-Bigas, T. A. Kisiel, D. C. DeWaal et al., “Genome-wide analysis of the H3K4 histone demethylase RBP2 reveals a transcriptional program controlling differentiation,” Molecular Cell, vol. 31, no. 4, pp. 520–530, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. F. A. Dick, “Structure-function analysis of the retinoblastoma tumor suppressor protein—is the whole a sum of its parts?” Cell Division, vol. 2, article 26, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. F. Fuks, W. A. Burgers, A. Brehm, L. Hughes-Davies, and T. Kouzarides, “DNA methyltransferase Dnmt1 associates with histone deacetylase activity,” Nature Genetics, vol. 24, no. 1, pp. 88–91, 2000. View at Publisher · View at Google Scholar · View at Scopus
  67. M. R. Rountree, K. E. Bachman, and S. B. Baylin, “DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci,” Nature Genetics, vol. 25, no. 3, pp. 269–277, 2000. View at Publisher · View at Google Scholar · View at Scopus
  68. Y. Ling, U. T. Sankpal, A. K. Robertson, J. G. McNally, T. Karpova, and K. D. Robertson, “Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription,” Nucleic Acids Research, vol. 32, no. 2, pp. 598–610, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. C. Stirzaker, D. S. Millar, C. L. Paul et al., “Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors,” Cancer Research, vol. 57, no. 11, pp. 2229–2237, 1997. View at Google Scholar · View at Scopus
  70. J. R. Melki, P. C. Vincent, and S. J. Clark, “Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia,” Cancer Research, vol. 59, no. 15, pp. 3730–3740, 1999. View at Google Scholar · View at Scopus
  71. S. Gonzalo, M. García-Cao, M. F. Fraga et al., “Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin,” Nature Cell Biology, vol. 7, no. 4, pp. 420–428, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. S. Talluri and F. A. Dick, “Regulation of transcription and chromatin structure by pRB: here, there and everywhere,” Cell Cycle, vol. 11, no. 17, pp. 3189–3198, 2012. View at Publisher · View at Google Scholar · View at Scopus
  73. H. Siddiqui, S. R. Fox, R. W. Gunawardena, and E. S. Knudsen, “Loss of RB compromises specific heterochromatin modifications and modulates HP1α dynamics,” Journal of Cellular Physiology, vol. 211, no. 1, pp. 131–137, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. C. E. Isaac, S. M. Francis, A. L. Martens et al., “The retinoblastoma protein regulates pericentric heterochromatin,” Molecular and Cellular Biology, vol. 26, no. 9, pp. 3659–3671, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. M. García-Cao, S. Gonzalo, D. Dean, and M. A. Blasco, “A role for the Rb family of proteins in controlling telomere length,” Nature Genetics, vol. 32, no. 3, pp. 415–419, 2002. View at Publisher · View at Google Scholar · View at Scopus
  76. G. Schotta, M. Lachner, K. Sarma et al., “A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin,” Genes & Development, vol. 18, no. 11, pp. 1251–1262, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. R. J. Bourgo, H. Siddiqui, S. Fox et al., “SWI/SNF deficiency results in aberrant chromatin organization, mitotic failure, and diminished proliferative capacity,” Molecular Biology of the Cell, vol. 20, no. 14, pp. 3192–3199, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. A. Gould, “Functions of mammalian Polycomb group and trithorax group related genes,” Current Opinion in Genetics & Development, vol. 7, no. 4, pp. 488–494, 1997. View at Publisher · View at Google Scholar · View at Scopus
  79. A. Schumacher and T. Magnuson, “Murine Polycomb- and trithorax-group genes regulate homeotic pathways and beyond,” Trends in Genetics, vol. 13, no. 5, pp. 167–170, 1997. View at Publisher · View at Google Scholar · View at Scopus
  80. J. A. Kennison, “The polycomb and trithorax group proteins of Drosophila: trans-regulators of homeotic gene function,” Annual Review of Genetics, vol. 29, no. 1, pp. 289–303, 1995. View at Publisher · View at Google Scholar · View at Scopus
  81. V. Pirrotta, “Polycombing the genome: PcG, trxG, and chromatin silencing,” Cell, vol. 93, no. 3, pp. 333–336, 1998. View at Publisher · View at Google Scholar
  82. N. P. Blackledge, N. R. Rose, and R. J. Klose, “Targeting Polycomb systems to regulate gene expression: modifications to a complex story,” Nature Reviews Molecular Cell Biology, vol. 16, no. 11, pp. 643–649, 2015. View at Publisher · View at Google Scholar · View at Scopus
  83. A. Dahiya, S. Wong, S. Gonzalo, M. Gavin, and D. C. Dean, “Linking the Rb and Polycomb pathways,” Molecular Cell, vol. 8, no. 3, pp. 557–568, 2001. View at Publisher · View at Google Scholar · View at Scopus
  84. Y. Kotake, T. Nakagawa, K. Kitagawa et al., “Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene,” Oncogene, vol. 30, no. 16, pp. 1956–1962, 2011. View at Publisher · View at Google Scholar
  85. A. Kuwabara and W. Gruissem, “Arabidopsis RETINOBLASTOMA-RELATED and Polycomb group proteins: cooperation during plant cell differentiation and development,” Journal of Experimental Botany, vol. 65, no. 10, pp. 2667–2676, 2014. View at Publisher · View at Google Scholar · View at Scopus
  86. A. J. Parry and M. Narita, “Old cells, new tricks: chromatin structure in senescence,” Mammalian Genome, vol. 27, no. 7, pp. 320–331, 2016. View at Publisher · View at Google Scholar
  87. W. R. Sellers, B. G. Novitch, S. Miyake et al., “Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth,” Genes & Development, vol. 12, no. 1, pp. 95–106, 1998. View at Publisher · View at Google Scholar · View at Scopus
  88. T.-T. Chen and J. Y. J. Wang, “Establishment of irreversible growth arrest in myogenic differentiation requires the RB LXCXE-binding function,” Molecular and Cellular Biology, vol. 20, no. 15, pp. 5571–5580, 2000. View at Publisher · View at Google Scholar · View at Scopus
  89. R. Váraljai, A. B. M. M. K. Islam, M. L. Beshiri, J. Rehman, N. Lopez-Bigas, and E. V. Benevolenskaya, “Increased mitochondrial function downstream from KDM5a histone demethylase rescues differentiation in pRB-deficient cells,” Genes & Development, vol. 29, no. 17, pp. 1817–1834, 2015. View at Publisher · View at Google Scholar · View at Scopus
  90. S. Ait-Si-Ali, V. Guasconi, L. Fritsch et al., “A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells,” The EMBO Journal, vol. 23, no. 3, pp. 605–615, 2004. View at Publisher · View at Google Scholar · View at Scopus
  91. G. P. Dimri, “What has senescence got to do with cancer?” Cancer Cell, vol. 7, no. 6, pp. 505–512, 2005. View at Publisher · View at Google Scholar · View at Scopus
  92. J. Sage, A. L. Miller, P. A. Pérez-Mancera, J. M. Wysocki, and T. Jacks, “Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry,” Nature, vol. 424, no. 6945, pp. 223–228, 2003. View at Publisher · View at Google Scholar · View at Scopus
  93. H.-J. Xu, Y. Zhou, W. Ji et al., “Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition,” Oncogene, vol. 15, no. 21, pp. 2589–2596, 1997. View at Publisher · View at Google Scholar · View at Scopus
  94. S. Talluri, C. E. Isaac, M. Ahmad et al., “A G1 checkpoint mediated by the retinoblastoma protein that is dispensable in terminal differentiation but essential for senescence,” Molecular and Cellular Biology, vol. 30, no. 4, pp. 948–960, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. A. Chicas, A. Kapoor, X. Wang et al., “H3K4 demethylation by Jarid1a and Jarid1b contributes to retinoblastoma-mediated gene silencing during cellular senescence,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 23, pp. 8971–8976, 2012. View at Publisher · View at Google Scholar · View at Scopus
  96. M. Vernier, V. Bourdeau, M.-F. Gaumont-Leclerc et al., “Regulation of E2Fs and senescence by PML nuclear bodies,” Genes & Development, vol. 25, no. 1, pp. 41–50, 2011. View at Publisher · View at Google Scholar · View at Scopus
  97. S. Talluri and F. A. Dick, “The retinoblastoma protein and PML collaborate to organize heterochromatin and silence E2F-responsive genes during senescence,” Cell Cycle, vol. 13, no. 4, pp. 641–651, 2014. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Vernier and G. Ferbeyre, “Complete senescence: RB and PML share the task,” Cell Cycle, vol. 13, no. 5, p. 696, 2014. View at Publisher · View at Google Scholar · View at Scopus
  99. L. Schulz and J. Tyler, “Heterochromatin focuses on senescence,” Molecular Cell, vol. 17, no. 2, pp. 168–170, 2005. View at Publisher · View at Google Scholar · View at Scopus
  100. M. Collado and M. Serrano, “The power and the promise of oncogene-induced senescence markers,” Nature Reviews Cancer, vol. 6, no. 6, pp. 472–476, 2006. View at Publisher · View at Google Scholar · View at Scopus
  101. R. Funayama and F. Ishikawa, “Cellular senescence and chromatin structure,” Chromosoma, vol. 116, no. 5, pp. 431–440, 2007. View at Publisher · View at Google Scholar · View at Scopus
  102. X. Shi, B. Tian, L. Liu et al., “Rb protein is essential to the senescence-associated heterochromatic foci formation induced by HMGA2 in primary WI38 cells,” Journal of Genetics and Genomics, vol. 40, no. 8, pp. 391–398, 2013. View at Publisher · View at Google Scholar · View at Scopus
  103. M. A. Mancini, B. Shan, J. A. Nickerson, S. Penman, and W. H. Lee, “The retinoblastoma gene product is a cell cycle-dependent, nuclear matrix-associated protein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 1, pp. 418–422, 1994. View at Publisher · View at Google Scholar · View at Scopus
  104. T.-A. Kim, J. Lim, S. Ota et al., “NRP/B, a novel nuclear matrix protein, associates with p110(RB) and is involved in neuronal differentiation,” The Journal of Cell Biology, vol. 141, no. 3, pp. 553–566, 1998. View at Publisher · View at Google Scholar · View at Scopus
  105. A. E. Radulescu and D. W. Cleveland, “NuMA after 30 years: the matrix revisited,” Trends in Cell Biology, vol. 20, no. 4, pp. 214–222, 2010. View at Publisher · View at Google Scholar · View at Scopus
  106. K. Tanaka and T. Hirota, “Chromosomal instability: a common feature and a therapeutic target of cancer,” Biochimica et Biophysica Acta—Reviews on Cancer, vol. 1866, no. 1, pp. 64–75, 2016. View at Publisher · View at Google Scholar
  107. F. A. Dick and S. M. Rubin, “Molecular mechanisms underlying RB protein function,” Nature Reviews Molecular Cell Biology, vol. 14, no. 5, pp. 297–306, 2013. View at Publisher · View at Google Scholar · View at Scopus
  108. S. B. Marquez-Vilendrer, K. Thompson, L. Lu, and D. Reisman, “Mechanism of BRG1 silencing in primary cancers,” Oncotarget, vol. 7, no. 35, pp. 56153–56169, 2016. View at Publisher · View at Google Scholar
  109. Y. Yokoyama, A. Matsumoto, M. Hieda et al., “Loss of histone H4K20 trimethylation predicts poor prognosis in breast cancer and is associated with invasive activity,” Breast Cancer Research, vol. 16, no. 3, article no. R66, 2014. View at Publisher · View at Google Scholar · View at Scopus
  110. Y.-C. Teng, C.-F. Lee, Y.-S. Li et al., “Histone demethylase RBP2 promotes lung tumorigenesis and cancer metastasis,” Cancer Research, vol. 73, no. 15, pp. 4711–4721, 2013. View at Publisher · View at Google Scholar · View at Scopus
  111. Y. He, I. Korboukh, J. Jin, and J. Huang, “Targeting protein lysine methylation and demethylation in cancers,” Acta Biochimica et Biophysica Sinica, vol. 44, no. 1, pp. 70–79, 2012. View at Publisher · View at Google Scholar · View at Scopus
  112. Y. Shi, F. Lan, C. Matson et al., “Histone demethylation mediated by the nuclear amine oxidase homolog LSD1,” Cell, vol. 119, no. 7, pp. 941–953, 2004. View at Publisher · View at Google Scholar · View at Scopus
  113. E. Metzger, M. Wissmann, N. Yin et al., “LSD1 demethylates repressive histone marks to promote androgen-receptor- dependent transcription,” Nature, vol. 437, no. 7057, pp. 436–439, 2005. View at Publisher · View at Google Scholar · View at Scopus
  114. J. Huang, R. Sengupta, A. B. Espejo et al., “p53 is regulated by the lysine demethylase LSD1,” Nature, vol. 449, no. 7158, pp. 105–108, 2007. View at Publisher · View at Google Scholar · View at Scopus
  115. U. Hasholzner, P. Stieber, A. Zimmermann et al., “Nuclear mitotic apparatus protein (NuMA) in benign and malignant diseases,” Anticancer Research, vol. 19, no. 4, pp. 2415–2420, 1999. View at Google Scholar · View at Scopus
  116. J. Briggman, R. Genduso, C. Camara et al., “NuMA: evaluation of a new biomarker for the detection of low stage colorectal cancer,” Anticancer Research, vol. 19, no. 4, pp. 2411–2414, 1999. View at Google Scholar · View at Scopus
  117. S. Kammerer, R. B. Roth, C. R. Hoyal et al., “Association of the NuMA region on chromosome 11q13 with breast cancer susceptibility,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 6, pp. 2004–2009, 2005. View at Publisher · View at Google Scholar · View at Scopus
  118. O. Kilpivaara, M. Rantanen, A. Tamminen, K. Aittomäki, C. Blomqvist, and H. Nevanlinna, “Comprehensive analysis of NuMA variation in breast cancer,” BMC Cancer, vol. 8, no. 1, article 71, 2008. View at Publisher · View at Google Scholar · View at Scopus
  119. R. Honda, H. Tanaka, and H. Yasuda, “Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53,” FEBS Letters, vol. 420, no. 1, pp. 25–27, 1997. View at Publisher · View at Google Scholar · View at Scopus
  120. Y. Haupt, R. Maya, A. Kazaz, and M. Oren, “Mdm2 promotes the rapid degradation of p53,” Nature, vol. 387, no. 6630, pp. 296–299, 1997. View at Publisher · View at Google Scholar · View at Scopus
  121. C. Uchida, S. Miwa, K. Kitagawa et al., “Enhanced Mdm2 activity inhibits pRB function via ubiquitin-dependent degradation,” The EMBO Journal, vol. 24, no. 1, pp. 160–169, 2005. View at Publisher · View at Google Scholar · View at Scopus
  122. P. Sdek, H. Ying, D. L. F. Chang et al., “MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein,” Molecular Cell, vol. 20, no. 5, pp. 699–708, 2005. View at Publisher · View at Google Scholar · View at Scopus
  123. S. Miwa, C. Uchida, K. Kitagawa et al., “Mdm2-mediated pRB downregulation is involved in carcinogenesis in a p53-independent manner,” Biochemical and Biophysical Research Communications, vol. 340, no. 1, pp. 54–61, 2006. View at Publisher · View at Google Scholar · View at Scopus
  124. C. Uchida, S. Miwa, T. Isobe et al., “Effects of MdmX on Mdm2-mediated downregulation of pRB,” FEBS Letters, vol. 580, no. 7, pp. 1753–1758, 2006. View at Publisher · View at Google Scholar · View at Scopus
  125. H. Zhang, L. Hu, W. Qiu et al., “MDMX exerts its oncogenic activity via suppression of retinoblastoma protein,” Oncogene, vol. 34, no. 44, pp. 5560–5569, 2015. View at Publisher · View at Google Scholar · View at Scopus
  126. L. Hu, H. Zhang, J. Bergholz, S. Sun, and Z.-X. J. Xiao, “MDM2/MDMX: master negative regulators for p53 and RB,” Molecular & Cellular Oncology, vol. 3, no. 2, Article ID e1106635, 2016. View at Publisher · View at Google Scholar
  127. J. Johnson, B. Thijssen, U. McDermott, M. Garnett, L. F. A. Wessels, and R. Bernards, “Targeting the RB-E2F pathway in breast cancer,” Oncogene, vol. 35, no. 37, pp. 4829–4835, 2016. View at Publisher · View at Google Scholar
  128. N. A. Laurie, S. L. Donovan, C.-S. Shih et al., “Inactivation of the p53 pathway in retinoblastoma,” Nature, vol. 444, no. 7115, pp. 61–66, 2006. View at Publisher · View at Google Scholar · View at Scopus
  129. W. Du, J. Wu, E. M. Walsh, Y. Zhang, C. Y. Chen, and Z.-X. J. Xiao, “Nutlin-3 affects expression and function of retinoblastoma protein: role of retinoblastoma protein in cellular response to nutlin-3,” The Journal of Biological Chemistry, vol. 284, no. 39, pp. 26315–26321, 2009. View at Publisher · View at Google Scholar · View at Scopus
  130. E. M. Walsh, M. Niu, J. Bergholz, and Z.-X. Jim Xiao, “Nutlin-3 down-regulates retinoblastoma protein expression and inhibits muscle cell differentiation,” Biochemical and Biophysical Research Communications, vol. 461, no. 2, pp. 293–299, 2015. View at Publisher · View at Google Scholar · View at Scopus
  131. E. Hamilton and J. R. Infante, “Targeting CDK4/6 in patients with cancer,” Cancer Treatment Reviews, vol. 45, pp. 129–138, 2016. View at Publisher · View at Google Scholar
  132. H. P. Mohammad and R. G. Kruger, “Antitumor activity of LSD1 inhibitors in lung cancer,” Molecular & Cellular Oncology, vol. 3, no. 2, Article ID e1117700, 2016. View at Publisher · View at Google Scholar
  133. L. Morera, M. Lübbert, and M. Jung, “Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy,” Clinical Epigenetics, vol. 8, no. 1, article 57, 2016. View at Publisher · View at Google Scholar